Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Lancet
Feng-Cai ZhuWei Chen

Abstract

A vaccine to protect against COVID-19 is urgently needed. We aimed to assess the safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine expressing the spike glycoprotein of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain. We did a dose-escalation, single-centre, open-label, non-randomised, phase 1 trial of an Ad5 vectored COVID-19 vaccine in Wuhan, China. Healthy adults aged between 18 and 60 years were sequentially enrolled and allocated to one of three dose groups (5 × 1010, 1 × 1011, and 1·5 × 1011 viral particles) to receive an intramuscular injection of vaccine. The primary outcome was adverse events in the 7 days post-vaccination. Safety was assessed over 28 days post-vaccination. Specific antibodies were measured with ELISA, and the neutralising antibody responses induced by vaccination were detected with SARS-CoV-2 virus neutralisation and pseudovirus neutralisation tests. T-cell responses were assessed by enzyme-linked immunospot and flow-cytometry assays. This study is registered with ClinicalTrials.gov, NCT04313127. Between March 16 and March 27, 2020, we screened 195 individuals for eligibility. Of them, 108 participants (51% male, 49% female...Continue Reading

Citations

Jun 4, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carol M KaoEvan J Anderson
Jul 10, 2020·Critical Reviews in Clinical Laboratory Sciences·Marco CiottiSergio Bernardini
Jul 15, 2020·The New England Journal of Medicine·Lisa A JacksonUNKNOWN mRNA-1273 Study Group
Jun 15, 2020·Allergy·Carmen RiggioniCezmi A Akdis
Jul 17, 2020·Clinical and Experimental Immunology·D BakerS Amor
Aug 5, 2020·Human Vaccines & Immunotherapeutics
Aug 11, 2020·Hypertension·Munehisa ShimamuraRyuichi Morishita
Aug 14, 2020·JAMA : the Journal of the American Medical Association·Shengli XiaXiaoming Yang
Aug 14, 2020·JAMA : the Journal of the American Medical Association·Mark J Mulligan
Jun 28, 2020·Journal of Virology·John P Moore, P J Klasse
Aug 4, 2020·Journal of the Pediatric Infectious Diseases Society·Stanley A Plotkin
Aug 29, 2020·Clinical Obesity·See KwokAkheel A Syed
Jul 15, 2020·Angewandte Chemie·Tingting YeBruno G De Geest
Sep 5, 2020·Advanced Healthcare Materials·Eduardo Ruiz-HitzkyPilar Aranda
Aug 7, 2020·American Journal of Physiology. Lung Cellular and Molecular Physiology·Julie A Bastarache
Jul 11, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yi-Min DongDa-Wei Ye
Sep 8, 2020·The Indian Journal of Medical Research·Rajesh Bhatia, Priya Abraham
Sep 8, 2020·Environmental Microbiology·Harald Brüssow
Sep 30, 2020·Human Vaccines & Immunotherapeutics·Zhiwei JiangJielai Xia
Aug 25, 2020·Journal of Medical Virology·Ji-Ming Chen
Jun 13, 2020·Expert Review of Respiratory Medicine·Arafat HussainAnant Mohan
Sep 30, 2020·Human Vaccines & Immunotherapeutics·Yashpal Singh MalikKuldeep Dhama
Sep 30, 2020·Human Vaccines & Immunotherapeutics·Harapan HarapanMudatsir Mudatsir
Sep 25, 2020·Current Opinion in HIV and AIDS·Yihan WangDongming Zhou
Sep 24, 2020·Nature·Florian Krammer
Jul 1, 2020·F1000Research·Surajit Chakraborty, Anirban Basu
Aug 5, 2020·AAPS PharmSciTech·Humzah JamshaidFakhar Ud Din
Jul 30, 2020·The New England Journal of Medicine·Kizzmekia S CorbettBarney S Graham
Sep 4, 2020·MSphere·Carolin LoosGalit Alter
Sep 12, 2020·Nature Reviews. Microbiology·Emmanuel MargolinEdward P Rybicki
Aug 28, 2020·Emerging Microbes & Infections·Zhigang YiZhenghong Yuan
Sep 29, 2020·Current Infectious Disease Reports·Shira RabinowiczItai M Pessach
Jun 6, 2020·Nature Reviews. Immunology·Peter J HotezMaria Elena Bottazzi
Sep 10, 2020·Experimental Hematology & Oncology·Ehtisham Ul HaqJiancheng Guo
Sep 4, 2020·Signal Transduction and Targeted Therapy·Xiangyu ChenLilin Ye
Sep 26, 2020·Frontiers in Immunology·Sana O AlturkiElias K Haddad
Sep 19, 2020·Nature Communications·Dianna L NgCharles Y Chiu
Sep 30, 2020·Nature Biotechnology·Laura DeFrancesco
Sep 20, 2020·International Journal of Molecular Sciences·Arun Samidurai, Anindita Das
Sep 11, 2020·The Journal of Experimental Medicine·Ting ZhouJun Wang

❮ Previous
Next ❯

Datasets Mentioned

BETA
MT291831.1

Methods Mentioned

BETA
ELISA
flow cytometry

Clinical Trials Mentioned

NCT04313127
NCT04341389

Software Mentioned

SAS
GraphPad Prism
SPICE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cadernos de saúde pública
Lais Cristina Barbosa Dos SantosBeatriz Aparecida Ozello Gutierrez
The New England Journal of Medicine
C M Holtzman
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Atle Fretheim
© 2021 Meta ULC. All rights reserved